Jonathan Miller
Stock Analyst at Evercore ISI Group
(0)
# 5148
Out of 5,218 analysts
11
Total ratings
0.00%
Success rate
-62.12%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Gracell Biotechnolog... | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Nov 27, 2023 | |
RayzeBio | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Oct 11, 2023 | |
ProKidney | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Sep 2, 2022 | |
Vaxxinity | Initiates Coverage On: In-Line | n/a | n/a | n/a | 1 | Apr 27, 2022 | |
Entrada Therapeutics | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | n/a | n/a | n/a | 2 | Sep 12, 2019 |